Graft Inflow Modulation by Splenic Artery Ligation for Portal Hyperperfusion Does Not Decrease Rates of Early Allograft Dysfunction in Adult Live Donor Liver Transplantation: A Randomized Control Trial
CardiologiaSobre o estudo
- Desenho
- Ensaio clínico randomizado
- Nível de evidência
- 2 · Nova evidência
- Revista
- Annals of surgery
- Publicado em
- 6 jun 2024
- Citações
- 14
O resumo deste estudo é do publisher e não tem licença aberta: por isso mostramos aqui só os dados do estudo, e o texto fica na fonte original, nos links abaixo.
O estudo original
Graft Inflow Modulation by Splenic Artery Ligation for Portal Hyperperfusion Does Not Decrease Rates of Early Allograft Dysfunction in Adult Live Donor Liver Transplantation: A Randomized Control Trial
Viniyendra Pamecha, Gattu Tharun, Nilesh Sadashiv Patil, Nihar Mohapatra, Anubhav Kumar, Shalini Thapar, Gaurav Sindwani, Udit Dhingra, Anil Yadav
Descritores MeSH
- Liver Transplantation
- Hypertension, Portal
- Splenic Artery
- Living Donors
- Primary Graft Dysfunction
- Middle Aged
- Adult
- Treatment Outcome
- Portal Pressure
- Portal Vein
Veja também
Estudos relacionados
- Small-for-Size Syndrome: Systemic Review in a Porcine Experimental Model
- Portal flow modulation by splenic artery ligation to prevent posthepatectomy liver failure: A randomized controlled trial
- Surgery for bilobar colorectal liver metastasis: from staged resections to liver transplantation. A systematic review of the outcomes of the different strategies
- Comparison of Carvedilol and Propranolol in Reducing the Portal Vein Pressure: A Systematic Review and Meta-analysis